<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01072500</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201701066-N</org_study_id>
    <secondary_id>3U01AG022376-05A2S1</secondary_id>
    <secondary_id>U01AG022376</secondary_id>
    <nct_id>NCT01072500</nct_id>
  </id_info>
  <brief_title>The LIFE Study - Lifestyle Interventions and Independence for Elders</brief_title>
  <acronym>LIFE</acronym>
  <official_title>The LIFE Study - Lifestyle Interventions and Independence for Elders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Based upon promising results from a pilot study among 424 sedentary older adults who were
      randomized to a physical activity intervention or a successful aging health education
      intervention, a Phase 3 multi-center randomized controlled trial is being conducted to
      compare a moderate-intensity physical activity program to a successful aging health education
      program in 1,600 sedentary older adults who are followed for an average of 2.7 years.

      The primary aim was to assess the long-term effects of the proposed interventions on the
      primary outcome of major mobility disability, defined as inability to walk 400 m.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As life expectancy in the United States continues to rise, the maintenance of physical
      independence among older Americans has emerged as a major clinical and public health
      priority. Efficient and reliable locomotion, or the ability to move without assistance, is a
      fundamental feature of human functioning. Older people who lose mobility are less likely to
      remain in the community, have higher rates of morbidity, mortality, and hospitalizations and
      experience a poorer quality of life. Several studies have shown that regular physical
      activity improves physical performance, but definitive evidence showing that mobility
      disability can be prevented was lacking. A Phase 3 randomized controlled trial was needed to
      fill this evidence gap.

      The LIFE Study was a Phase 3, multicenter randomized controlled trial (RCT) designed to
      compare a moderate-intensity physical activity program to a successful aging health education
      program in 1,600 sedentary older persons who are followed for an average of 2.7 years. The
      primary outcome was major mobility disability, defined as inability to walk 400 m. Secondary
      outcomes include cognitive function based on the Digit Symbol Substitution Test (DSST) and
      the Hopkins Verbal Learning Test (HVLT); serious fall injuries; persistent mobility
      disability; the combined outcome of major mobility disability or death; disability in
      activities of daily living; and cost-effectiveness. Tertiary outcomes include the combined
      outcome of mild cognitive impairment or dementia, a composite measure of the cognitive
      assessment battery, physical performance within pre-specified subgroups defined on the basis
      of race, gender and baseline physical performance, sleep-wake disturbances, dyspnea,
      ventilatory capacity, cardiopulmonary events, and cardiovascular events.

      The physical activity intervention consists primarily of walking at moderate intensity, lower
      extremity resistance exercises, balance exercises, stretching and behavioral counseling. The
      successful aging intervention consists of health education seminars regarding health-related
      matters and upper extremity stretching exercises. This trial provides definitive evidence
      regarding whether physical activity is effective and practical for preventing major mobility
      disability. These results will have crucial implications for public health prevention in a
      rapidly aging society, and will fill an important gap in knowledge for practicing
      evidence-based geriatric medicine. The study will also yield valuable information concerning
      the efficacy and effectiveness of physical activity across a broad spectrum of important
      health outcomes. The study will impact both clinical practice and public health policy, and
      will, therefore, benefit individuals and society.

      The Coordinating Center was at the University of Florida and the Data Management Analysis and
      Quality Control Center (DMAQC) was at Wake Forest University School of Medicine. The 8 field
      sites participating in the LIFE Study are University of Florida, Gainesville, Florida;
      Northwestern University, Chicago, Illinois; Pennington Biomedical Research Center, Baton
      Rouge, Louisiana; University of Pittsburgh, Pittsburgh, Pennsylvania; Stanford University,
      Palo Alto, California; Tufts University, Boston, Massachusetts; Wake Forest University,
      Winston-Salem, North Carolina; and Yale University, New Haven, Connecticut.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major Mobility Disability, Defined as Incapacity to Walk 400 Meters</measure>
    <time_frame>Median 2.7 years/Average 2.6 years</time_frame>
    <description>The primary outcome of major mobility disability was defined as the inability to complete a 400-m walk test within 15 minutes without sitting and without the help of another person or walker. Use of a cane was acceptable. Participants were asked to walk 400 m at their usual pace, without overexerting, on a 20 meter course for 10 laps (40 meters/lap). Participants were allowed to stop for up to 1 minute for fatigue or related symptoms. When major mobility disability could not be objectively measured because of the inability of the participant to come to the clinic and absence of a suitable walking course at the participant's home, institution, or hospital, an alternative adjudication of the outcome was based on objective inability to walk 4 meters in less than 10 seconds, or self-, proxy-, or medical record-reported inability to walk across a room. If participants met these alternative criteria, they would not be able to complete the 400 meter walk within 15 minutes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Persistent Mobility Disability (Assessed Every 6 Months)</measure>
    <time_frame>Median 2.7 years/Average 2.6 years</time_frame>
    <description>The assessment of major mobility disability (the inability to complete a 400-m walk test within 15 minutes without sitting and without the help of another person or walker. Use of a cane was acceptable. Participants were asked to walk 400m at their usual pace, without overexerting, on a 20 meter course for 10 laps (40 meters/lap). Participants were allowed to stop for up to 1 minute for fatigue or related symptoms. When MMD could not be objectively measured because of the inability of the participant to come to the clinic and absence of a suitable walking course at the participant's home, institution, or hospital, an alternative adjudication of the outcome was based on objective inability to walk 4 meters in less than 10 seconds, or self-, proxy-, or medical record-reported inability to walk across a room. If participants met these alternative criteria, they would not be able to complete the 400 m walk within 15 minutes.) at two consecutive time points or MMD followed by death.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1635</enrollment>
  <condition>Sedentary Lifestyle</condition>
  <condition>Risk of Disability</condition>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Physical Activity</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The physical activity intervention consists primarily of walking at moderate intensity, lower extremity resistance exercises, balance exercises, stretching and behavioral counseling.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Successful Aging</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The successful aging intervention consists of health education seminars regarding health-related matters and upper extremity stretching exercises.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physical Activity</intervention_name>
    <description>The physical activity intervention consists primarily of walking at moderate intensity, lower extremity resistance exercises, balance exercises, stretching and behavioral counseling.</description>
    <arm_group_label>Physical Activity</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Successful Aging</intervention_name>
    <description>The successful aging intervention consists of health education seminars regarding health-related matters and upper extremity stretching exercises.</description>
    <arm_group_label>Successful Aging</arm_group_label>
    <other_name>Health Education</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age 70 to 89 years; (2) summary score &lt;10 on the short physical performance battery
             (SPPB) (45% are &lt;8);90 (3) sedentary lifestyle; (4) ability to complete the 400 m walk
             test without an assistive device; and (5) willingness to be randomized to either
             intervention group.

             Exclusion Criteria:

             Exclusion Criteria for Factors that May Limit Adherence to Interventions or Affect
             Conduct of the Trial • Unable or unwilling to give informed consent or accept
             randomization in either study group • Current diagnosis of schizophrenia, other
             psychotic disorders, or bipolar disorder

               -  Current consumption of more than 14 alcoholic drinks per week

               -  Plans to relocate to out of the study area within the next 2 years or plans to be
                  out of the study area for more than 6 consecutive weeks in the next year

               -  Self-reported inability to walk across a small room

               -  The use of a walker to complete the 400 m walk and/or unable to complete the 400
                  m walk without sitting down or the help of another person

               -  Another member of the household is a participant in the Life Study

               -  Residence too far from the intervention site

               -  Residence in a nursing home

               -  Difficulty in communication with study personnel due to speech or hearing
                  problems

               -  Modified Mini-Mental State Exam (3MSE) score below the cutoff for education:

             African American, 9+ yrs 76, &lt;9 yrs 70; English Speaking Non-African American, 9+ yrs
             80, &lt;9 yrs 76; Spanish Speaking, 9+ yrs 80, &lt;9 yrs 70

               -  Participation in LIFE-Pilot study

               -  Other medical, psychiatric, or behavioral factors that in the judgment of the
                  Principal Investigator may interfere with study participation or the ability to
                  follow the intervention protocol

             Exclusion Criteria for Underlying Diseases Likely to Limit Lifespan and/or Affect the
             Safety of the Interventions

             • Severe arthritis (either osteoarthritis or rheumatoid arthritis)

             • Cancer requiring treatment in the past three years, except for non-melanoma skin
             cancers or cancers that have clearly been cured or in the opinion of the investigator
             carry an excellent prognosis (e.g., Stage 1 cervical cancer)

             • Lung disease requiring either regular use of corticosteroid pills or injections or
             the use of supplemental oxygen

             • Development of chest pain or severe shortness of breath on a 400 m self-paced walk
             test

             • Cardiovascular disease (including New York Heart Association Class III or IV
             congestive heart failure, clinically significant aortic stenosis, history or cardiac
             arrest, use of a cardiac defibrillator or uncontrolled angina)

             • Parkinson's disease or other serious neurological disorder

             • Renal disease requiring dialysis

             • Other illness of such severity that life expectancy is considered to be less than 12
             months

             • Conditions not specifically mentioned above may serve as criteria for exclusion at
             the discretion of the clinical site

             Temporary Exclusion Criteria

             • Uncontrolled hypertension (systolic blood pressure &gt; 200 mmHg and/or diastolic blood
             pressure &gt; 110 mmHg).

             • Uncontrolled diabetes with recent weight loss, diabetic coma or frequent insulin
             reactions.

               -  Stroke, hip fracture, hip or knee replacement, or spinal surgery in the past 6
                  months.

               -  Serious conduction disorder (e.g., 3rd degree heart block), uncontrolled
                  arrhythmia, or new Q waves or ST-segment depressions (&gt;3 mm) on ECG.

               -  Myocardial infarction, major heart surgery (i.e., valve replacement or bypass
                  surgery), stroke, deep vein thrombosis or pulmonary embolus in the past 6 months.

               -  Undergoing physical therapy or cardiopulmonary rehabilitation

               -  Currently enrolled in another randomized trial involving lifestyle or
                  pharmaceutical interventions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco Pahor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pennington Biodmedical Research</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.thelifestudy.org</url>
    <description>The LIFE Study website</description>
  </link>
  <reference>
    <citation>LIFE Study Investigators, Pahor M, Blair SN, Espeland M, Fielding R, Gill TM, Guralnik JM, Hadley EC, King AC, Kritchevsky SB, Maraldi C, Miller ME, Newman AB, Rejeski WJ, Romashkan S, Studenski S. Effects of a physical activity intervention on measures of physical performance: Results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study. J Gerontol A Biol Sci Med Sci. 2006 Nov;61(11):1157-65. Erratum in: J Gerontol A Biol Sci Med Sci. 2007 Mar;62(3):337.</citation>
    <PMID>17167156</PMID>
  </reference>
  <reference>
    <citation>Fielding RA, Rejeski WJ, Blair S, Church T, Espeland MA, Gill TM, Guralnik JM, Hsu FC, Katula J, King AC, Kritchevsky SB, McDermott MM, Miller ME, Nayfield S, Newman AB, Williamson JD, Bonds D, Romashkan S, Hadley E, Pahor M; LIFE Research Group. The Lifestyle Interventions and Independence for Elders Study: design and methods. J Gerontol A Biol Sci Med Sci. 2011 Nov;66(11):1226-37. doi: 10.1093/gerona/glr123. Epub 2011 Aug 8.</citation>
    <PMID>21825283</PMID>
  </reference>
  <results_reference>
    <citation>Rejeski WJ, Marsh AP, Anton S, Chen SH, Church T, Gill TM, Guralnik JM, Glynn NW, King AC, Rushing J, Ip EH; LIFE Research Group. The MAT-sf: clinical relevance and validity. J Gerontol A Biol Sci Med Sci. 2013 Dec;68(12):1567-74. doi: 10.1093/gerona/glt068. Epub 2013 May 17.</citation>
    <PMID>23685766</PMID>
  </results_reference>
  <results_reference>
    <citation>Espeland MA, Katula JA, Rushing J, Kramer AF, Jennings JM, Sink KM, Nadkarni NK, Reid KF, Castro CM, Church T, Kerwin DR, Williamson JD, Marottoli RA, Rushing S, Marsiske M, Rapp SR; LIFE Study Group. Performance of a computer-based assessment of cognitive function measures in two cohorts of seniors. Int J Geriatr Psychiatry. 2013 Dec;28(12):1239-50. doi: 10.1002/gps.3949. Epub 2013 Apr 16.</citation>
    <PMID>23589390</PMID>
  </results_reference>
  <results_reference>
    <citation>Marsh AP, Lovato LC, Glynn NW, Kennedy K, Castro C, Domanchuk K, McDavitt E, Rodate R, Marsiske M, McGloin J, Groessl EJ, Pahor M, Guralnik JM; LIFE Study Research Group. Lifestyle interventions and independence for elders study: recruitment and baseline characteristics. J Gerontol A Biol Sci Med Sci. 2013 Dec;68(12):1549-58. doi: 10.1093/gerona/glt064. Epub 2013 May 28.</citation>
    <PMID>23716501</PMID>
  </results_reference>
  <results_reference>
    <citation>McDermott MM, Applegate WB, Bonds DE, Buford TW, Church T, Espeland MA, Gill TM, Guralnik JM, Haskell W, Lovato LC, Pahor M, Pepine CJ, Reid KF, Newman A. Ankle brachial index values, leg symptoms, and functional performance among community-dwelling older men and women in the lifestyle interventions and independence for elders study. J Am Heart Assoc. 2013 Nov 12;2(6):e000257. doi: 10.1161/JAHA.113.000257.</citation>
    <PMID>24222666</PMID>
  </results_reference>
  <results_reference>
    <citation>Rejeski WJ, Axtell R, Fielding R, Katula J, King AC, Manini TM, Marsh AP, Pahor M, Rego A, Tudor-Locke C, Newman M, Walkup MP, Miller ME; LIFE Study Investigator Group. Promoting physical activity for elders with compromised function: the lifestyle interventions and independence for elders (LIFE) study physical activity intervention. Clin Interv Aging. 2013;8:1119-31. doi: 10.2147/CIA.S49737. Epub 2013 Sep 12.</citation>
    <PMID>24049442</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2010</study_first_submitted>
  <study_first_submitted_qc>February 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 22, 2010</study_first_posted>
  <results_first_submitted>December 8, 2015</results_first_submitted>
  <results_first_submitted_qc>March 21, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 18, 2016</results_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aging</keyword>
  <keyword>Physical Activity</keyword>
  <keyword>Exercise</keyword>
  <keyword>Sedentary Lifestyle</keyword>
  <keyword>Mobility</keyword>
  <keyword>Disability</keyword>
  <keyword>Falls</keyword>
  <keyword>Cost effectiveness</keyword>
  <keyword>Behavioral counseling</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>If an investigator outside of a LIFE study team would like access to the LIFE coded dataset, this individual must go through the following steps:
Request access to the LIFE website for the purposes of submitting a P&amp;P proposal to obtain access to the Coded Datasets by going to the LIFE website (www.thelifestudy.org) and clicking on the button &quot;Request for Non-LIFE investigator Access&quot; and completing the request form.
Access would be granted to the LIFE website where access to would be provided to the data dictionary, data documentation, and protocol, in addition to the Manuscript Proposal Submission Form.
A proposal would be submitted (per current guidelines) to LIFE and reviewed through the usual channels.
If approved the Investigator would be sent a Coded Data Use Agreement document to be signed and sent back to the DMAQC for filing.
Access to the Coded Datasets would be granted for a period of 10 days.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>1,635 participants were randomized over 21-months, with the target of 1,600 reached late Nov 2011. The 1st randomization occurred 3/12/10, and the final randomization on 12/27/11. Participants in the recruitment pipeline completed screening and testing visits and were randomized; hence, the total randomized exceeded the target.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Physical Activity</title>
          <description>The physical activity intervention consists primarily of walking at moderate intensity, lower extremity resistance exercises, balance exercises, stretching and behavioral counseling.</description>
        </group>
        <group group_id="P2">
          <title>Successful Aging (Health Education)</title>
          <description>The successful aging intervention consists of health education seminars regarding health-related matters and upper extremity stretching exercises.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="818"/>
                <participants group_id="P2" count="817"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="794"/>
                <participants group_id="P2" count="803"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline characteristics were similar in the 2 groups.</population>
      <group_list>
        <group group_id="B1">
          <title>Physical Activity</title>
          <description>The physical activity intervention consists primarily of walking at moderate intensity, lower extremity resistance exercises, balance exercises, stretching and behavioral counseling.</description>
        </group>
        <group group_id="B2">
          <title>Successful Aging</title>
          <description>The successful aging intervention consists of health education seminars regarding health-related matters and upper extremity stretching exercises.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="818"/>
            <count group_id="B2" value="817"/>
            <count group_id="B3" value="1635"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>These represent data that was measured and analyzed. We have verified the standard deviation is the same in both arms.</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="78.7" spread="5.2"/>
                    <measurement group_id="B2" value="79.1" spread="5.2"/>
                    <measurement group_id="B3" value="78.9" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="547"/>
                    <measurement group_id="B2" value="551"/>
                    <measurement group_id="B3" value="1098"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="271"/>
                    <measurement group_id="B2" value="266"/>
                    <measurement group_id="B3" value="537"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="604"/>
                    <measurement group_id="B2" value="635"/>
                    <measurement group_id="B3" value="1239"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="163"/>
                    <measurement group_id="B2" value="125"/>
                    <measurement group_id="B3" value="288"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other/Mixed</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Refused/Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Education</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>No formal eduction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elementary School (k-8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>High school/equivalent (9-12)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="248"/>
                    <measurement group_id="B2" value="236"/>
                    <measurement group_id="B3" value="484"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>College (13-17)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="321"/>
                    <measurement group_id="B2" value="320"/>
                    <measurement group_id="B3" value="641"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Graduate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="194"/>
                    <measurement group_id="B2" value="208"/>
                    <measurement group_id="B3" value="402"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total SPPB Score</title>
          <description>This is the Short Physical Performance Battery with a Scale from 0-12. Lower scores represent worse physical performance. Three subscales (balance, gait speed, and chair stand) are summed to create the total score.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.4" spread="1.6"/>
                    <measurement group_id="B2" value="7.3" spread="1.6"/>
                    <measurement group_id="B3" value="7.4" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>3MSE Score, 0-100 scale, mean</title>
          <description>Modified Mini-Mental State Exam Higher scores indicate better cognition score</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="91.5" spread="5.6"/>
                    <measurement group_id="B2" value="91.6" spread="5.5"/>
                    <measurement group_id="B3" value="91.5" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>CHAMPS 18 Total Score</title>
          <description>Community Health Activities Model Program for Seniors - Activity Questionnaire Score is based on hours of moderate-intensity exercise-related activities per week (frequency/week) Total score is the sum of each activity's frequency. The minimum total score is 0 and the maximum is 168.</description>
          <units>hours/week</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15.9" spread="32.1"/>
                    <measurement group_id="B2" value="18.2" spread="33.8"/>
                    <measurement group_id="B3" value="17.0" spread="33.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total Cholesterol</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="179.3" spread="39.6"/>
                    <measurement group_id="B2" value="178.5" spread="39.9"/>
                    <measurement group_id="B3" value="178.9" spread="39.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Systolic Blood Pressure</title>
          <description>mean of two measures</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="127.9" spread="18.1"/>
                    <measurement group_id="B2" value="127.0" spread="17.8"/>
                    <measurement group_id="B3" value="127.4" spread="18.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diastolic Blood Pressure</title>
          <description>mean of two measures</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68.7" spread="10.3"/>
                    <measurement group_id="B2" value="67.7" spread="10.1"/>
                    <measurement group_id="B3" value="68.2" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight (kg)</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81.9" spread="18.4"/>
                    <measurement group_id="B2" value="82.0" spread="19.3"/>
                    <measurement group_id="B3" value="81.9" spread="18.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index, mean</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.1" spread="5.9"/>
                    <measurement group_id="B2" value="30.3" spread="6.2"/>
                    <measurement group_id="B3" value="30.2" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>High blood pressure/hypertension</title>
          <description>The number of participants in this measurement (high blood pressure) are the ones who self-reported this history.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="573"/>
                    <measurement group_id="B2" value="578"/>
                    <measurement group_id="B3" value="1151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Heart Attack/Coronary/MI</title>
          <description>The number of participants in this measurement (heart attack/coronary/MI) are the ones who self-reported this history.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="69"/>
                    <measurement group_id="B3" value="129"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Heart failure/congestive heart failure</title>
          <description>The number of participants in this measurement (heart failure/congestive heart failure) are the ones who self-reported this history.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pacemaker</title>
          <description>The number of participants in this measurement (pacemaker) are the ones who self-reported this history.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Stroke</title>
          <description>The number of participants in this measurement (stroke) are the ones who self-reported this history.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="109"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cancer</title>
          <description>The number of participants in this measurement (cancer) are the ones who self-reported this history.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="178"/>
                    <measurement group_id="B2" value="192"/>
                    <measurement group_id="B3" value="370"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes/High Blood Sugar</title>
          <description>The number of participants in this measurement (diabetes/high blood sugar) are the ones who self-reported this history.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="198"/>
                    <measurement group_id="B2" value="216"/>
                    <measurement group_id="B3" value="414"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chronic lung disease</title>
          <description>The number of participants in this measurement (chronic lung disease) are the ones who self-reported this history.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="130"/>
                    <measurement group_id="B2" value="123"/>
                    <measurement group_id="B3" value="253"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Major Mobility Disability, Defined as Incapacity to Walk 400 Meters</title>
        <description>The primary outcome of major mobility disability was defined as the inability to complete a 400-m walk test within 15 minutes without sitting and without the help of another person or walker. Use of a cane was acceptable. Participants were asked to walk 400 m at their usual pace, without overexerting, on a 20 meter course for 10 laps (40 meters/lap). Participants were allowed to stop for up to 1 minute for fatigue or related symptoms. When major mobility disability could not be objectively measured because of the inability of the participant to come to the clinic and absence of a suitable walking course at the participant’s home, institution, or hospital, an alternative adjudication of the outcome was based on objective inability to walk 4 meters in less than 10 seconds, or self-, proxy-, or medical record–reported inability to walk across a room. If participants met these alternative criteria, they would not be able to complete the 400 meter walk within 15 minutes.</description>
        <time_frame>Median 2.7 years/Average 2.6 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Physical Activity</title>
            <description>The physical activity intervention consists primarily of walking at moderate intensity, lower extremity resistance exercises, balance exercises, stretching and behavioral counseling.</description>
          </group>
          <group group_id="O2">
            <title>Successful Aging</title>
            <description>The successful aging intervention consists of health education seminars regarding health-related matters and upper extremity stretching exercises.</description>
          </group>
        </group_list>
        <measure>
          <title>Major Mobility Disability, Defined as Incapacity to Walk 400 Meters</title>
          <description>The primary outcome of major mobility disability was defined as the inability to complete a 400-m walk test within 15 minutes without sitting and without the help of another person or walker. Use of a cane was acceptable. Participants were asked to walk 400 m at their usual pace, without overexerting, on a 20 meter course for 10 laps (40 meters/lap). Participants were allowed to stop for up to 1 minute for fatigue or related symptoms. When major mobility disability could not be objectively measured because of the inability of the participant to come to the clinic and absence of a suitable walking course at the participant’s home, institution, or hospital, an alternative adjudication of the outcome was based on objective inability to walk 4 meters in less than 10 seconds, or self-, proxy-, or medical record–reported inability to walk across a room. If participants met these alternative criteria, they would not be able to complete the 400 meter walk within 15 minutes.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="818"/>
                <count group_id="O2" value="817"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="246"/>
                    <measurement group_id="O2" value="290"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>Regression, Cox</method>
            <method_desc>To compare interventions, we used a likelihood ratio test from a Cox regression model, stratified by field center and sex.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.82</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.69</ci_lower_limit>
            <ci_upper_limit>0.98</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Mobility Disability (Assessed Every 6 Months)</title>
        <description>The assessment of major mobility disability (the inability to complete a 400-m walk test within 15 minutes without sitting and without the help of another person or walker. Use of a cane was acceptable. Participants were asked to walk 400m at their usual pace, without overexerting, on a 20 meter course for 10 laps (40 meters/lap). Participants were allowed to stop for up to 1 minute for fatigue or related symptoms. When MMD could not be objectively measured because of the inability of the participant to come to the clinic and absence of a suitable walking course at the participant’s home, institution, or hospital, an alternative adjudication of the outcome was based on objective inability to walk 4 meters in less than 10 seconds, or self-, proxy-, or medical record–reported inability to walk across a room. If participants met these alternative criteria, they would not be able to complete the 400 m walk within 15 minutes.) at two consecutive time points or MMD followed by death.</description>
        <time_frame>Median 2.7 years/Average 2.6 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Physical Activity</title>
            <description>The physical activity intervention consists primarily of walking at moderate intensity, lower extremity resistance exercises, balance exercises, stretching and behavioral counseling.
Physical Activity: The physical activity intervention consists primarily of walking at moderate intensity, lower extremity resistance exercises, balance exercises, stretching and behavioral counseling.</description>
          </group>
          <group group_id="O2">
            <title>Successful Aging</title>
            <description>The successful aging intervention consists of health education seminars regarding health-related matters and upper extremity stretching exercises.
Successful Aging: The successful aging intervention consists of health education seminars regarding health-related matters and upper extremity stretching exercises.</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Mobility Disability (Assessed Every 6 Months)</title>
          <description>The assessment of major mobility disability (the inability to complete a 400-m walk test within 15 minutes without sitting and without the help of another person or walker. Use of a cane was acceptable. Participants were asked to walk 400m at their usual pace, without overexerting, on a 20 meter course for 10 laps (40 meters/lap). Participants were allowed to stop for up to 1 minute for fatigue or related symptoms. When MMD could not be objectively measured because of the inability of the participant to come to the clinic and absence of a suitable walking course at the participant’s home, institution, or hospital, an alternative adjudication of the outcome was based on objective inability to walk 4 meters in less than 10 seconds, or self-, proxy-, or medical record–reported inability to walk across a room. If participants met these alternative criteria, they would not be able to complete the 400 m walk within 15 minutes.) at two consecutive time points or MMD followed by death.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="818"/>
                <count group_id="O2" value="817"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120"/>
                    <measurement group_id="O2" value="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.006</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.72</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.57</ci_lower_limit>
            <ci_upper_limit>0.91</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected from each participant beginning with screening until closeout of the study. Participants were queried every 6 months but could report adverse events in-between visits. Participants were followed for an average of 2.6 years.</time_frame>
      <desc>To minimize reporting bias, adverse events originating from the blinded assessments are presented. Blinded assessments were completed every 6 months.
Non-serious AEs were collected without regard to the specific AE term.</desc>
      <group_list>
        <group group_id="E1">
          <title>Physical Activity</title>
          <description>The physical activity intervention consists primarily of walking at moderate intensity, lower extremity resistance exercises, balance exercises, stretching and behavioral counseling.</description>
        </group>
        <group group_id="E2">
          <title>Successful Aging</title>
          <description>The successful aging intervention consists of health education seminars regarding health-related matters and upper extremity stretching exercises.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="404" subjects_at_risk="818"/>
                <counts group_id="E2" subjects_affected="373" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANEMIA</sub_title>
                <counts group_id="E1" events="15" subjects_affected="10" subjects_at_risk="818"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>BLOOD AND LYMPHATIC SYSTEM DISORDERS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>FEBRILE NEUTROPENIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE CORONARY SYNDROME</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="818"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>AORTIC VALVE DISEASE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ASYSTOLE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ATRIAL FIBRILLATION</sub_title>
                <counts group_id="E1" events="28" subjects_affected="23" subjects_at_risk="818"/>
                <counts group_id="E2" events="23" subjects_affected="19" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ATRIAL FLUTTER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ATRIOVENTRICULAR BLOCK COMPLETE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>CARDIAC ARREST</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="818"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>CARDIAC DISORDERS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="818"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>CHEST PAIN - CARDIAC</sub_title>
                <counts group_id="E1" events="24" subjects_affected="18" subjects_at_risk="818"/>
                <counts group_id="E2" events="14" subjects_affected="12" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>CONDUCTION DISORDER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HEART FAILURE</sub_title>
                <counts group_id="E1" events="24" subjects_affected="20" subjects_at_risk="818"/>
                <counts group_id="E2" events="23" subjects_affected="16" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>MYOCARDIAL INFARCTION</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="818"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PALPITATIONS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PAROXYSMAL ATRIAL TACHYCARDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PERICARDITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>RESTRICTIVE CARDIOMYOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SINUS BRADYCARDIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="818"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SUPRAVENTRICULAR TACHYCARDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>VENTRICULAR ARRHYTHMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>VENTRICULAR TACHYCARDIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>VERTIGO</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="818"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>ADRENAL INSUFFICIENCY</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ENDOCRINE DISORDERS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HYPERPARATHYROIDISM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HYPERTHYROIDISM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HYPOPARATHYROIDISM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="818"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>COLITIS</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>COLONIC FISTULA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>COLONIC HEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>COLONIC OBSTRUCTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>COLONIC PERFORATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>CONSTIPATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>DIARRHEA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>DYSPEPSIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>DYSPHAGIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ENTEROCOLITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ESOPHAGEAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ESOPHAGEAL STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ESOPHAGEAL ULCER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>GASTRIC HEMORRHAGE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>GASTRIC ULCER</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>GASTRITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>GASTROESOPHAGEAL REFLUX DISEASE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL DISORDERS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="8" subjects_affected="5" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HEMORRHOIDS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ILEAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>INTRA-ABDOMINAL HEMORRHAGE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>JEJUNAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>LOWER GASTROINTESTINAL HEMORRHAGE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>OBSTRUCTION GASTRIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PANCREATIC NECROSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PANCREATITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>RECTAL HEMORRHAGE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>RECTAL PERFORATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>RECTAL STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SMALL INTESTINAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>STOMACH PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>DEATH NOS</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>EDEMA LIMBS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>EDEMA TRUNK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>FATIGUE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>FEVER</sub_title>
                <counts group_id="E1" events="5" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>FLU LIKE SYMPTOMS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>GAIT DISTURBANCE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="49" subjects_affected="31" subjects_at_risk="818"/>
                <counts group_id="E2" events="46" subjects_affected="27" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>INJECTION SITE REACTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>MALAISE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>NON-CARDIAC CHEST PAIN</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="818"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>CHOLECYSTITIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>GALLBLADDER NECROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>GALLBLADDER OBSTRUCTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>GALLBLADDER PAIN</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HEPATIC FAILURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HEPATIC HEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HEPATOBILIARY DISORDERS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>ALLERGIC REACTION</sub_title>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ANAPHYLAXIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>IMMUNE SYSTEM DISORDERS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ANORECTAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>APPENDICITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>APPENDICITIS PERFORATED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>BILIARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>BLADDER INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>BONE INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>BRONCHIAL INFECTION</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>CATHETER RELATED INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>DEVICE RELATED INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ENCEPHALITIS INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ENTEROCOLITIS INFECTIOUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>GALLBLADDER INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>INFECTIONS AND INFESTATIONS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>JOINT INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>KIDNEY INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>LARYNGITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>LUNG INFECTION</sub_title>
                <counts group_id="E1" events="17" subjects_affected="15" subjects_at_risk="818"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>OVARIAN INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PHARYNGITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PROSTATE INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SALIVARY GLAND INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SEPSIS</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SINUSITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SKIN INFECTION</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="818"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SOFT TISSUE INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>UPPER RESPIRATORY INFECTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="818"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>WOUND INFECTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>ANKLE FRACTURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>FALL</sub_title>
                <counts group_id="E1" events="29" subjects_affected="28" subjects_at_risk="818"/>
                <counts group_id="E2" events="35" subjects_affected="31" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>FRACTURE</sub_title>
                <counts group_id="E1" events="19" subjects_affected="18" subjects_at_risk="818"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HIP FRACTURE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>INJURY, POISONING AND PROCEDURAL COMPLICATIONS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>INTRAOPERATIVE CARDIAC INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SEROMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SPINAL FRACTURE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>WOUND DEHISCENCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>WRIST FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>CREATININE INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>INR INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PLATELET COUNT DECREASED</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>WHITE BLOOD CELL DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>DEHYDRATION</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="818"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HYPERCALCEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HYPERGLYCEMIA</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HYPERKALEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HYPERURICEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HYPOCALCEMIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HYPOGLYCEMIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HYPONATREMIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>METABOLISM AND NUTRITION DISORDERS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>TUMOR LYSIS SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ARTHRALGIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ARTHRITIS</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="818"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>BACK PAIN</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="818"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>BONE PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>CHEST WALL PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>GENERALIZED MUSCLE WEAKNESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>JOINT EFFUSION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>JOINT RANGE OF MOTION DECREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>JOINT RANGE OF MOTION DECREASED CERVICAL SPINE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>JOINT RANGE OF MOTION DECREASED LUMBAR SPINE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>MUSCLE WEAKNESS LOWER LIMB</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDER - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="818"/>
                <counts group_id="E2" events="18" subjects_affected="17" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL DEFORMITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>MYALGIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>MYOSITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>NECK PAIN</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>OSTEOPOROSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PAIN IN EXTREMITY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SOFT TISSUE NECROSIS UPPER LIMB</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>MYELODYSPLASTIC SYNDROME</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS) - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="31" subjects_affected="24" subjects_at_risk="818"/>
                <counts group_id="E2" events="31" subjects_affected="19" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>ATAXIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>CENTRAL NERVOUS SYSTEM NECROSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>CEREBROSPINAL FLUID LEAKAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>COGNITIVE DISTURBANCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>DEPRESSED LEVEL OF CONSCIOUSNESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>DIZZINESS</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>DYSESTHESIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>FACIAL MUSCLE WEAKNESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>FACIAL NERVE DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HYDROCEPHALUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>INTRACRANIAL HEMORRHAGE</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="818"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ISCHEMIA CEREBROVASCULAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>LETHARGY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>NERVOUS SYSTEM DISORDERS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PERIPHERAL MOTOR NEUROPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PERIPHERAL SENSORY NEUROPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PRESYNCOPE</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>RADICULITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SEIZURE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>STROKE</sub_title>
                <counts group_id="E1" events="19" subjects_affected="15" subjects_at_risk="818"/>
                <counts group_id="E2" events="25" subjects_affected="22" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SYNCOPE</sub_title>
                <counts group_id="E1" events="15" subjects_affected="13" subjects_at_risk="818"/>
                <counts group_id="E2" events="17" subjects_affected="15" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>TRANSIENT ISCHEMIC ATTACKS</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="818"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>TREMOR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>VASOVAGAL REACTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>ANXIETY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>CONFUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>DELIRIUM</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>DEPRESSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HALLUCINATIONS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>MANIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SUICIDE ATTEMPT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE KIDNEY INJURY</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>CHRONIC KIDNEY DISEASE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HEMATURIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PROTEINURIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>RENAL AND URINARY DISORDERS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>RENAL CALCULI</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>URINARY INCONTINENCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>URINARY RETENTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>URINARY TRACT OBSTRUCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>URINARY TRACT PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>PROSTATIC OBSTRUCTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>REPRODUCTIVE SYSTEM AND BREAST DISORDERS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>UTERINE PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>VAGINAL HEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>APNEA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ASPIRATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>ATELECTASIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>BRONCHIAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>BRONCHOSPASM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>COUGH</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>DYSPNEA</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="818"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HICCUPS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HYPOXIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PLEURAL EFFUSION</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PNEUMONITIS</sub_title>
                <counts group_id="E1" events="23" subjects_affected="17" subjects_at_risk="818"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PNEUMOTHORAX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PRODUCTIVE COUGH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PULMONARY FIBROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PULMONARY HYPERTENSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>RESPIRATORY FAILURE</sub_title>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="818"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="818"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>WHEEZING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>BULLOUS DERMATITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>RASH MACULO-PAPULAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SKIN AND SUBCUTANEOUS TISSUE DISORDERS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SKIN ULCERATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>PROSTECTOMY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>SURGICAL AND MEDICAL PROCEDURES - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="75" subjects_affected="67" subjects_at_risk="818"/>
                <counts group_id="E2" events="86" subjects_affected="74" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>HEMATOMA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="818"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>HYPOTENSION</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>PERIPHERAL ISCHEMIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>THROMBOEMBOLIC EVENT</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="818"/>
                <counts group_id="E2" events="12" subjects_affected="10" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>VASCULAR DISORDERS - OTHER, SPECIFY</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="817"/>
              </event>
              <event>
                <sub_title>VISCERAL ARTERIAL ISCHEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="181" subjects_at_risk="818"/>
                <counts group_id="E2" subjects_affected="88" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>non-serious AES</sub_title>
                <counts group_id="E1" events="181" subjects_affected="181" subjects_at_risk="818"/>
                <counts group_id="E2" events="88" subjects_affected="88" subjects_at_risk="817"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Michael Miller</name_or_title>
      <organization>Wake Forest School of Medicine</organization>
      <phone>336-716-6837</phone>
      <email>mmiller@wakehealth.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

